132 related articles for article (PubMed ID: 9662257)
1. Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis.
Pfeiffer P; Nexø E; Bentzen SM; Clausen PP; Andersen K; Rose C
Br J Cancer; 1998 Jul; 78(1):96-9. PubMed ID: 9662257
[TBL] [Abstract][Full Text] [Related]
2. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections.
Pfeiffer P; Clausen PP; Andersen K; Rose C
Br J Cancer; 1996 Jul; 74(1):86-91. PubMed ID: 8679464
[TBL] [Abstract][Full Text] [Related]
3. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
[TBL] [Abstract][Full Text] [Related]
4. [Epidermal growth factor receptor in non-small cell cancer of the lung].
Díez M; Maestro ML; Torres A; Hernando F; Ortega MD; García-Asenjo JA; Picardo A; Mugüerza JM; Sánchez-Pernaute A; Balibrea JL
Arch Bronconeumol; 1994; 30(6):282-6. PubMed ID: 8087386
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer.
Jiang LY; Bi R; Ding FB; Wang MS; Mei J; He Y
J BUON; 2016; 21(2):341-8. PubMed ID: 27273943
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
Dittadi R; Gion M; Pagan V; Brazzale A; Del Maschio O; Bargossi A; Busetto A; Bruscagnin G
Br J Cancer; 1991 Oct; 64(4):741-4. PubMed ID: 1654986
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptors in non-small cell lung cancer.
Veale D; Ashcroft T; Marsh C; Gibson GJ; Harris AL
Br J Cancer; 1987 May; 55(5):513-6. PubMed ID: 3038157
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].
Niu Y; Wang H; Zhang G; Ma J; Wei B; Ma Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):919-23. PubMed ID: 25609130
[TBL] [Abstract][Full Text] [Related]
9. EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry.
Mraihi Z; Ben Amar J; Bouacha H; Rammeh S; Hila L
BMC Pulm Med; 2018 Aug; 18(1):132. PubMed ID: 30092812
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
[TBL] [Abstract][Full Text] [Related]
12. EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor.
Koo JS; Kim SH
Neoplasma; 2011; 58(1):27-34. PubMed ID: 21067263
[TBL] [Abstract][Full Text] [Related]
13. A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
Christensen ME; Engbaek F; Therkildsen MH; Bretlau P; Nexø E
Br J Cancer; 1995 Dec; 72(6):1487-93. PubMed ID: 8519664
[TBL] [Abstract][Full Text] [Related]
14. Correlation between survivin expression and prognosis in non-small cell lung cancer.
Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
[TBL] [Abstract][Full Text] [Related]
16. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
[TBL] [Abstract][Full Text] [Related]
17. DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival.
Dazzi H; Thatcher N; Hasleton PS; Swindell R
Respir Med; 1990 May; 84(3):217-23. PubMed ID: 2171051
[TBL] [Abstract][Full Text] [Related]
18. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.
Onn A; Choe DH; Herbst RS; Correa AM; Munden RF; Truong MT; Vaporciyan AA; Isobe T; Gilcrease MZ; Marom EM
Radiology; 2005 Oct; 237(1):342-7. PubMed ID: 16183941
[TBL] [Abstract][Full Text] [Related]
19. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
Giatromanolaki A; Gorgoulis V; Chetty R; Koukourakis MI; Whitehouse R; Kittas C; Veslemes M; Gatter KC; Iordanoglou I
Anticancer Res; 1996; 16(2):987-93. PubMed ID: 8687165
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunohistochemistry of epidermal growth factor receptor in breast cancer.
Robertson KW; Reeves JR; Lannigan AK; Going JJ; Cooke TG; Stanton PD
Arch Pathol Lab Med; 2002 Feb; 126(2):177-81. PubMed ID: 11825114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
